Psychoactive drug
Top View
- Piperazine Derivatives As Dangerous Abused Compounds
- Agenda Item 6.1 the Development Of
- Β-Arrestin 1 and 2 Modulation of LSD-Evoked Responses
- New Psychoactive Substances in Australia
- MDMA (“Ecstasy”)
- Piperazine Derivatives As Dangerous Abused Compounds
- Analysis of Submissions: Proposal to Classify BZP and Related
- Ecstasy (MDMA): Effects and Patterns of Use Reported by Users in São Paulo Ecstasy (MDMA): Efeitos E Padrões De Uso Relatados Por Usuários De São Paulo
- “The Short History of New Psychoactive Substances in Ukraine”
- Prevalence and Demographic Correlates of Substance Use Among Adults with Mental Illness in Eastern Cape, South Africa: a Cross-Sectional Study
- Psychotoxic Or Psychedelic G
- New Psychoactive Substances. a Challenge to Public Health
- Neuroscience of Psychoactive Substance Use and Dependence
- Volume C: Addiction Medications and Special Populations
- A Comparative Study of LSD and LSD Analogues' Effects and User Profile
- Critical Review Report Agenda Item 5.1
- From PCP to MXE: a Comprehensive Review of the Non-Medical Use of Dissociative Drugs Hamilton Morrisa and Jason Wallachb*
- Drug Fact Sheet